U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763834) titled 'Uromodulin as a Biomarker in Lupus Nephritis' on Aug. 09.
Brief Summary: Evaluation of Uromodulin as a biomarker of renal histological activity/ Chronicity indices in lupus nephritis
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Uromodulin
SLE
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Mariam Edwar Zaki Bishay, Assiut University
Published by HT Digital Content Services with permission from Health Daily Digest....